Literature DB >> 30224542

Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining.

D Vicky de Boer1, Arjen Brink1, Marijke Buijze1, Marijke Stigter-van Walsum1, Keith D Hunter2, Bauke Ylstra3, Elisabeth Bloemena3,4, C René Leemans1, Ruud H Brakenhoff5.   

Abstract

Head and neck squamous cell carcinomas (HNSCC) develop in fields of genetically altered cells. These fields are often dysplastic and a subset can be recognized as (erythro)leukoplakia, but most are macroscopically invisible. There is a lack of adequate treatment options to eradicate these fields, whereas they underlie the development of primary tumors as well as part of the local relapses. Unfortunately, there are almost no representative cellular models available to identify suitable treatment options. To this end, clinical biopsy specimens (n = 98) were cultured from normal appearing mucosa of the surgical margins of patients with primary HNSCCs (n = 32) to generate precancer cell culture models. This collection was extended with six previously established precancer cell cultures. Genetic analysis was performed on cultures with an extended life span (≥20 population doublings), the previously established cultures, and some randomly selected cultures. In total, cancer-associated changes were detected in 18 out of 34 (53%) cultures analyzed, which appeared to be independent of life span. A variety of genetic changes were identified, including somatic mutations as well as chromosomal copy-number aberrations (CNA). Loss of CDKN2A/p16Ink4A and mutations in TP53/p53 were most prominent. Remarkably, in some of these precancer cell cultures only chromosomal CNAs were detected, and none of the frequently occurring driver mutations. IMPLICATIONS: The precancer cell cultures, characterized herein, form a representative collection of field models that can be exploited to identify and validate new therapeutic strategies to prevent primary HNSCCs and local relapses. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 30224542     DOI: 10.1158/1541-7786.MCR-18-0445

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  10 in total

1.  Extracellular Prostaglandins E1 and E2 and Inflammatory Cytokines Are Regulated by the Senescence Program in Potentially Premalignant Oral Keratinocytes.

Authors:  Lee Peng Karen-Ng; Usama Sharif Ahmad; Luis Gomes; Keith David Hunter; Hong Wan; Eleni Hagi-Pavli; Eric Kenneth Parkinson
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

2.  Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell-like properties and phosphoinositide 3-kinase inhibitor insensitivity.

Authors:  Khoa A Nguyen; Madison J Keith; Stephen B Keysar; Spencer C Hall; Anamol Bimali; Antonio Jimeno; Xiao-Jing Wang; Christian D Young
Journal:  Mol Carcinog       Date:  2022-04-13       Impact factor: 5.139

3.  Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death.

Authors:  Anne M van Harten; Marijke Buijze; Richard van der Mast; Martin A Rooimans; Sanne R Martens-de Kemp; Costa Bachas; Arjen Brink; Marijke Stigter-van Walsum; Rob M F Wolthuis; Ruud H Brakenhoff
Journal:  Oncogenesis       Date:  2019-06-17       Impact factor: 7.485

4.  The Extracellular Metabolome Stratifies Low and High Risk Potentially Premalignant Oral Keratinocytes and Identifies Citrate as a Potential Non-Invasive Marker of Tumour Progression.

Authors:  Lee Peng Karen-Ng; Emma Louise James; Abish Stephen; Mark Henry Bennett; Maria Elzbieta Mycielska; Eric Kenneth Parkinson
Journal:  Cancers (Basel)       Date:  2021-08-21       Impact factor: 6.639

Review 5.  Unmet Needs and Perspectives in Oral Cancer Prevention.

Authors:  Jebrane Bouaoud; Paolo Bossi; Moshe Elkabets; Sandra Schmitz; Léon C van Kempen; Pierre Martinez; Sankar Jagadeeshan; Ingrid Breuskin; Gerwin J Puppels; Caroline Hoffmann; Keith D Hunter; Christian Simon; Jean-Pascal Machiels; Vincent Grégoire; Chloé Bertolus; Ruud H Brakenhoff; Senada Koljenović; Pierre Saintigny
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

6.  Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.

Authors:  Usama Sharif Ahmad; Eric Kenneth Parkinson; Hong Wan
Journal:  Mol Oncol       Date:  2022-03-01       Impact factor: 7.449

7.  Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.

Authors:  Yewen Shi; Tongxin Xie; Bingbing Wang; Rong Wang; Yu Cai; Bo Yuan; Frederico O Gleber-Netto; Xiangjun Tian; Alanis E Rodriguez-Rosario; Abdullah A Osman; Jing Wang; Curtis R Pickering; Xiaoyong Ren; Andrew G Sikora; Jeffrey N Myers; Roberto Rangel
Journal:  Commun Biol       Date:  2022-07-28

Review 8.  Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization.

Authors:  Annouk S Pierik; C René Leemans; Ruud H Brakenhoff
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

9.  Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition.

Authors:  Anne M van Harten; D Vicky de Boer; Sanne R Martens-de Kemp; Marijke Buijze; Sonja H Ganzevles; Keith D Hunter; C René Leemans; Victor W van Beusechem; Rob M F Wolthuis; Renée X de Menezes; Ruud H Brakenhoff
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

10.  Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.

Authors:  Xiaotian Li; Lu Liu; Jianyun Zhang; Ming Ma; Lisha Sun; Xuefen Li; Heyu Zhang; Jianbin Wang; Yanyi Huang; Tiejun Li
Journal:  Sci China Life Sci       Date:  2021-08-02       Impact factor: 6.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.